chitosan has been researched along with flurbiprofen in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 4 (30.77) | 2.80 |
| Authors | Studies |
|---|---|
| Anraku, M; Arahira, M; Imai, T; Khaled, KA; Mady, FM; Otagiri, M; Seo, H; Yamasaki, K | 1 |
| Luo, Q; Pan, W; Zhang, X; Zhao, J | 1 |
| Chauhan, MK; Kawadkar, J | 1 |
| Dhar, KL; Jain, N; Sareen, R | 1 |
| Chen, H; Li, P; Pan, H; Pan, W; Wang, H; Wang, X; Yuan, Y | 1 |
| Jain, DD; Joshi, PN; Shinde, UA; Singh, K | 1 |
| Öztürk, AA; Şenel, B | 1 |
| Aminu, N; Chan, SY; Toh, SM; Yam, MF | 1 |
| Chen, S; Jiang, J; Yan, X; Zhao, J; Zhu, T | 1 |
| Erol, ÜH; Işıklan, N | 1 |
| Pande, S; Solanki, A; Vashi, J | 1 |
| Feng, J; Han, J; Hong, W; Li, K; Li, Y; Sheng, Y; Sun, X; Tian, B; Xie, S; Yan, F | 1 |
| Erol, ÜH; Güncüm, E; Işıklan, N | 1 |
13 other study(ies) available for chitosan and flurbiprofen
| Article | Year |
|---|---|
Enhancement of dissolution and bioavailability of flurbiprofen by low molecular weight chitosans.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Chitosan; Drug Compounding; Excipients; Flurbiprofen; Intestinal Absorption; Magnetic Resonance Spectroscopy; Male; Molecular Weight; Pharmaceutical Solutions; Rats; Solubility; X-Ray Diffraction | 2010 |
Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system.
Topics: Adhesiveness; Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chitosan; Cornea; Drug Carriers; Drug Compounding; Flurbiprofen; In Vitro Techniques; Male; Microscopy, Electron, Transmission; Nanostructures; Oligosaccharides; Particle Size; Permeability; Rabbits; Surface Properties | 2011 |
Intra-articular delivery of genipin cross-linked chitosan microspheres of flurbiprofen: preparation, characterization, in vitro and in vivo studies.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Chitosan; Cross-Linking Reagents; Emulsions; Flurbiprofen; Injections, Intra-Articular; Iridoids; Knee Joint; Male; Microscopy, Electron, Scanning; Microspheres; Particle Size; Rats; Rats, Sprague-Dawley; Spectroscopy, Fourier Transform Infrared; Transition Temperature | 2012 |
Development of colon specific microspheres of flurbiprofen for inflammatory bowel disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calorimetry, Differential Scanning; Chitosan; Colon; Flurbiprofen; Inflammatory Bowel Diseases; Microspheres; Polymethacrylic Acids; X-Ray Diffraction | 2013 |
The potential use of novel chitosan-coated deformable liposomes in an ocular drug delivery system.
Topics: Administration, Ophthalmic; Animals; Chitosan; Cornea; Drug Compounding; Drug Delivery Systems; Drug Liberation; Flurbiprofen; Liposomes; Male; Particle Size; Permeability; Rabbits; Tissue Culture Techniques | 2016 |
Preparation and Evaluation of N-Trimethyl Chitosan Nanoparticles of Flurbiprofen for Ocular Delivery.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chitosan; Conjunctivitis, Bacterial; Drug Carriers; Drug Compounding; Drug Delivery Systems; Flurbiprofen; Magnetic Resonance Spectroscopy; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Spectroscopy, Fourier Transform Infrared | 2019 |
New approaches to tumor therapy with siRNA-decorated and chitosan-modified PLGA nanoparticles.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cancer Pain; Cell Line, Tumor; Cell Survival; Chitosan; Cyclooxygenase Inhibitors; Drug Carriers; Flurbiprofen; Folic Acid; Humans; Mice; Nanoparticles; Neoplasms; Particle Size; Polylactic Acid-Polyglycolic Acid Copolymer; RNA, Small Interfering; STAT3 Transcription Factor | 2019 |
A dual-action chitosan-based nanogel system of triclosan and flurbiprofen for localised treatment of periodontitis.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Chickens; Chitosan; Drug Delivery Systems; Flurbiprofen; Hydrogels; Male; Nanogels; Nanoparticles; Particle Size; Periodontitis; Rats; Rats, Sprague-Dawley; Triclosan | 2019 |
Regulating Preparation Of Functional Alginate-Chitosan Three-Dimensional Scaffold For Skin Tissue Engineering.
Topics: Alginates; Animals; Cell Proliferation; Cells, Cultured; Chitosan; Fibroblasts; Flurbiprofen; Freeze Drying; Male; Mice; Microscopy, Electron, Scanning; Porosity; Skin; Skin Transplantation; Spectroscopy, Fourier Transform Infrared; Tissue Engineering; Tissue Scaffolds | 2019 |
Design and evaluation of temperature-responsive chitosan/hydroxypropyl cellulose blend nanospheres for sustainable flurbiprofen release.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cell Survival; Cellulose; Chitosan; Delayed-Action Preparations; Drug Carriers; Drug Design; Drug Liberation; Flurbiprofen; Kinetics; Nanospheres; Particle Size; Spectroscopy, Fourier Transform Infrared; Temperature; Thermogravimetry; X-Ray Diffraction | 2020 |
QbD-Enabled Systematic Development of Ileo-Colonic Targeted Novel Mucoadhesive Microspheres of Flurbiprofen.
Topics: Chitosan; Colitis, Ulcerative; Drug Delivery Systems; Flurbiprofen; Humans; Microspheres; Particle Size; Polymethacrylic Acids; Spectroscopy, Fourier Transform Infrared | 2022 |
N-acetylcysteine functionalized chitosan oligosaccharide-palmitic acid conjugate enhances ophthalmic delivery of flurbiprofen and its mechanisms.
Topics: Acetylcysteine; Animals; Chickens; Chitosan; Cornea; Female; Flurbiprofen; Oligosaccharides; Palmitic Acid; Particle Size; Rabbits | 2022 |
Development of chitosan-graphene oxide blend nanoparticles for controlled flurbiprofen delivery.
Topics: Chitosan; Drug Carriers; Flurbiprofen; Nanoparticles; Particle Size; Polymers; Spectroscopy, Fourier Transform Infrared | 2023 |